This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Sapiens (SPNS) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Sapiens (SPNS) delivered earnings and revenue surprises of -3.03% and 1.42%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Microsoft (MSFT) Q2 Earnings Beat Estimates
by Zacks Equity Research
Microsoft (MSFT) delivered earnings and revenue surprises of 2.20% and 0.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for December 29th
by Zacks Equity Research
SPNS, CRS, DHT, DCBO and ENTX have been added to the Zacks Rank #1 (Strong Buy) List on December 29, 2022.
Best Income Stocks to Buy for December 29th
by Zacks Equity Research
SPNS and CRS made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 29, 2022.
Sapiens' (SPNS) Expanding Customer Base Augments Growth
by Zacks Equity Research
Sapiens International's (SPNS) strong product portfolio addresses the digitization needs of the Insurance sector, which attracts new customers.
Should Value Investors Pick Sapiens International (SPNS) Stock?
by Zacks Equity Research
Let's see if Sapiens International Corporation N.V. (SPNS) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Sapiens (SPNS) Q3 Earnings Beat Estimates
by Zacks Equity Research
Sapiens (SPNS) delivered earnings and revenue surprises of 3.45% and 2.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Pros Holdings (PRO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Pros Holdings (PRO) delivered earnings and revenue surprises of 64.71% and 2.95%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
SS&C Technologies (SSNC) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
SS&C Technologies (SSNC) delivered earnings and revenue surprises of -1.71% and 1.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Manhattan Associates (MANH) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Manhattan Associates (MANH) delivered earnings and revenue surprises of 15.79% and 6.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
4 Dividend-Paying Tech Stocks Under $20 to Watch in 2022
by Vasundhara Sawalka
Here we present four high-quality dividend-paying tech stocks - SPNS, ABST, HPE and ERIC - that are trading for less than $20 a share with the potential to continue growth in 2022.
Sapiens' (SPNS) Expanding Partner Base Strengthens Prospect
by Zacks Equity Research
Sapiens (SPNS) expands its network in North America with CGI, ForMotiv, Hi Marley, ODG by MCG and Opterrix as partners.
Sapiens' (SPNS) Latest AI-Based Solution Strengthens Portfolio
by Zacks Equity Research
Sapiens International's (SPNS) latest artificial intelligence (AI)-based Decision Automated Logic Extraction (ALE) solution helps in the successful digital transformation of insurance providers.
Sapiens International's (SPNS) ReinsurancePro Selected by AEGIS
by Zacks Equity Research
Sapiens' (SPNS) ReinsurancePro gets selected by AEGIS to automate and modernize its reinsurance policy to improve efficiency and enable auditable processing.
Sapiens (SPNS) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Sapiens (SPNS) delivered earnings and revenue surprises of -10% and 4.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sapiens (SPNS) Soars 8.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Sapiens (SPNS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Datadog (DDOG) Makes OpenTelemetry Protocol Support Available
by Zacks Equity Research
Datadog (DDOG) announces the general availability of OpenTelemetry Protocol Support for Datadog Agent, making it easier to trace and analyze telemetry data for organizations.
Sapiens (SPNS) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Sapiens (SPNS) delivered earnings and revenue surprises of 14.81% and 0.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Sapiens' (SPNS) IllustrationPro Selected by Guardian Group
by Zacks Equity Research
Sapiens (SPNS) announces that Guardian Group has selected its IllustrationPro and ApplicationPro softwares for upgrading its life and health operations.
Sapiens' (SPNS) ReinsurancePro Selected by Applied Underwriters
by Zacks Equity Research
Sapiens (SPNS) recently announced that Applied Underwriters has selected its ReinsurancePro to automate its reinsurance administration, accounting, analysis and reporting.
Sapiens (SPNS) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Sapiens (SPNS) delivered earnings and revenue surprises of 10.34% and 0.86%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Cutera (CUTR) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cutera (CUTR) delivered earnings and revenue surprises of 18.18% and 9.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Synopsys (SNPS) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Synopsys (SNPS) delivered earnings and revenue surprises of 1.27% and 0.56%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?
Sapiens (SPNS) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Sapiens (SPNS) delivered earnings and revenue surprises of 6.90% and 0.16%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Sapiens (SPNS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Sapiens (SPNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.